risedronic acid has been researched along with Glomerulonephritis, Minimal Change in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Steroid-induced osteoporosis is a serious adverse effect of this drug." | 2.75 | Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome. ( Amemiya, N; Itabashi, M; Karasawa, K; Kawanishi, K; Kojima, C; Moriyama, T; Nitta, K; Ogawa, T; Shimizu, A; Shiohira, S; Sugiura, H; Takei, T; Tsuchiya, K; Tsukada, M; Uchida, K, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takei, T | 1 |
| Itabashi, M | 1 |
| Tsukada, M | 1 |
| Sugiura, H | 1 |
| Moriyama, T | 1 |
| Kojima, C | 1 |
| Shiohira, S | 1 |
| Shimizu, A | 1 |
| Karasawa, K | 1 |
| Amemiya, N | 1 |
| Kawanishi, K | 1 |
| Ogawa, T | 1 |
| Uchida, K | 1 |
| Tsuchiya, K | 1 |
| Nitta, K | 1 |
1 trial available for risedronic acid and Glomerulonephritis, Minimal Change
| Article | Year |
|---|---|
Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome.
Topics: Adult; Bone Density; Bone Density Conservation Agents; Etidronic Acid; Female; Humans; Hydroxycholec | 2010 |